Gyre Therapeutics, Inc. GYRE All Other Segments — Income Tax Expense Benefit
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s all other segments — income tax expense benefit.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s all other segments — income tax expense benefit?
- Gyre Therapeutics, Inc. (GYRE) reported all other segments — income tax expense benefit of $0 in Q1 2026.
- What does all other segments — income tax expense benefit mean?
- This metric represents the total income tax expense or benefit allocated to the 'All Other Segments' business unit. It reflects the tax impact of the segment's financial performance on the company's overall tax position. Monitoring this helps investors understand the tax efficiency and jurisdictional impact of non-core business activities.